Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis

Psoriasis is a common, chronic and relapsing inflammatory skin disease. It affects approximately 2% of the western population and has no cure. Combination therapy for psoriasis often proves more efficacious and better tolerated than monotherapy with a single drug. Combination therapy could be admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Wing Man, Heard, Charles M., White, Alex W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834954/
https://www.ncbi.nlm.nih.gov/pubmed/24300448
http://dx.doi.org/10.3390/pharmaceutics5020232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834954/
https://www.ncbi.nlm.nih.gov/pubmed/24300448
http://dx.doi.org/10.3390/pharmaceutics5020232

Ejemplares similares